Advertisement
AMA draws line in the sand on Medicaid caps, drug price transparency

AMA draws line in the sand on Medicaid caps, drug price transparency

By Maria Castellucci , Matthew Weinstock and Steven Ross Johnson  |  June 17, 2017

The American Medical Association last week left no room for doubt about its stance on legislative proposals to cap Medicaid funding: That would be "disastrous," AMA board member Dr. Carl Sirio said.

Increasing transparency on generic drug cost data could save $4 billion

Increasing transparency on generic drug cost data could save $4 billion

By Alex Kacik  |  June 15, 2017

Making actual generic drug acquisition costs available to third-party payers would empower health plans to negotiate lower rates and essentially level the playing field in a pharmaceutical supply chain that's shrouded in secrecy, according to a new paper.

Blink Health ends Express Scripts contract over insulin program

Blink Health ends Express Scripts contract over insulin program

By Alex Kacik  |  June 14, 2017

Blink Health and Express Scripts partnered with Eli Lilly to provide up to a 40% discount on the drugmaker's insulin. An Express Scripts spokesman said Blink ended the contract because it did not want an exclusive relationship with the PBM, a violation of their agreement.

New York's Nassau County sues drugmakers over opioid crisis

By Robin D. Schatz  |  June 13, 2017

Citing "exorbitant" expenses in addressing the mounting opioid crisis, Nassau County on Monday joined a growing number of local governments suing major pharmaceutical companies, accusing them of contributing to the explosive growth in opioid addiction and overdose deaths.

High court ruling speeds up generic biotech drug approval

By Associated Press  |  June 12, 2017

A unanimous Supreme Court is speeding up the time for generic biotech drugs to become available to the public in a ruling that means a loss of billions in sales to the makers of original versions.

Drug distributors, PBMs seek to block Cherokee Nation opioid suit

By Alex Kacik  |  June 12, 2017

Several major pharmacy benefit managers and drug distributors have sued the Cherokee Nation over its attempt to make them pay for the widespread distribution of opioids that has allegedly contributed to the opioid addiction that has beset its tribal members.

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print